News

February, 2017 – News - Where is the Future of Drug Discovery for Cancer?

June, 2016 – News - Have drug hunters finally cracked KRas?

March, 2016 – Publication - Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State

February, 2016 – Publication - Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism

November 20, 2013 - Press Release - Wellspring Biosciences Founder Publishes In Nature On Discovery of Small Molecule Inhibitors of K-Ras

SAN DIEGO, California, Nov. 20, 2013 - Groundbreaking Research Offers Potential to Develop Therapies To Treat An Important Genetic Lesion in Human Cancer.

November 20, 2013 - News & Views - Pocket of Opportunity

February 27, 2013 - Press Release - Araxes Pharma Enters Into Cancer Drug Discovery and Development Agreement With JanssenBiotech

SAN DIEGO, California, Feb. 27, 2013 - Araxes Pharma LLC announced today it has entered into an exclusive arrangement with Janssen Biotech, Inc. to develop first-inclass therapeutics against a certain target for the treatment of cancer.